Quality of Life in Japanese Pediatric Alopecia Areata

JRCT ID: jRCT1030230428

Registered date:03/11/2023

Basic Information

• Recruitment status: Not Recruiting
• Health condition(s) or Problem(s) studied: Pediatric alopecia areata
• Date of first enrollment: 03/11/2023
• Target sample size: 300
• Study type: Observational

Outcome(s)

• Primary Outcome: Children's Dermatology Life Quality Index (CDLQI)
• Secondary Outcome: Subpopulation analysis of CDLQI and Pediatric Quality of Life Inventory (PedsQL) scores per hair loss range.

Key inclusion & exclusion criteria

• Age minimum: >= 5age old
• Age maximum: <= 15age 11month 5weeks old
• Gender: Both
• Include criteria: Diagnosed with AA and age 5 to 15 years

Exclude criteria

Have primarily diffuse type of AA (characterized by widespread reduction of hair
density rather than clearly defined patches of hair loss).
2. Are currently experiencing other forms of alopecia including, but not limited to,
telogen effluvium, chemotherapy-induced hair loss, or any other concomitant
conditions (for example, Down syndrome, tinea capitis, psoriasis, lupus
erythematosus, or secondary syphilis) that would interfere with the evaluation of the
effect of study medication on AA.

Related Information

• Primary Sponsor: Yamanaka Kenichi